Answers are grounded in this paper and cite their sources.
When tenecteplase was used without adjunctive antithrombotic therapy during advanced life support for out-of-hospital cardiac arrest, we did not detect an improvement in outcome, in comparison with placebo. (ClinicalTrials.gov number, NCT00157261.)
No takes yet. Share an insight, caveat, or question.
Böttiger et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: